# Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)

Study · id `cardio:ct-nct00979628` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00979628](<https://clinicaltrials.gov/study/NCT00979628>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00979628

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 375 participants.

## Technical summary

Registry record NCT00979628. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2014-04-24.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 375 participants (enrolled count; ClinicalTrials.gov record NCT00979628, source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT00979628, source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)
- Primary completion: 2012-03 (actual) (ClinicalTrials.gov record NCT00979628, source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)
- Completion: 2012-06 (actual) (ClinicalTrials.gov record NCT00979628, source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)
- Results first posted: 2014-04-24 (ClinicalTrials.gov record NCT00979628, source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT00979628, source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00979628-2018-10-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
- Acronym: Basal-Plus
- Condition: Type 2 Diabetes
- Condition: Hyperglycemia
- Intervention (Drug): sliding scale regular insulin (SSRI)
- Intervention (Drug): Basal Bolus
- Intervention (Drug): Basal Plus
- Lead sponsor: Guillermo Umpierrez, MD
- Lead sponsor class: OTHER
- Collaborator: Sanofi
- Collaborator class: INDUSTRY
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: Texas A&M University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Sanofi (`cardio:org-sanofi`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial (`cardio:pubmed-23435159`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes (`cardio:pubmed-25168125`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 47dba4df0bbeeed5719154573774a8e370b2a0fda544cda48102989e1fc44a2b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
